Oracle Health Sciences InForm Cloud Service 6.1 Helps Life Sciences Organizations Accelerate Study Start-Up and Expand Risk-Based Monitoring Precision

WASHINGTON, DC -- (Marketwired) -- 06/16/15 -- DIA 2015 -- Oracle Health Sciences (NYSE: ORCL) today announced the availability of Oracle Health Sciences InForm Cloud Service 6.1. The latest release of the Oracle Health Sciences InForm data capture and management platform provides trial sponsors and contract research organizations (CROs) with a complete, integrated solution designed to accelerate trial timelines, lower costs, deliver higher data quality, and reduce risk.

The Oracle Health Sciences InForm Cloud Service 6.1 platform supports today's complex trial protocols and environments with advanced data capture/query management and real-time, actionable visibility into data, as well as standards-based, integrated workflows. This latest release enables trial sponsors and CROs to further increase clinical trial speed, efficiency, and accuracy with new capabilities including:

• Expanded risk-based monitoring capacity that enables source verification at the individual and subject level. This new functionality supports more precise, risk-based monitoring, as well as expanded use of adaptive trials, which, in turn, boost efficiency and reduce costs. Oracle Health Sciences InForm Cloud Service 6.1's risk-based monitoring capabilities are included as part of the core solution, avoiding the one-off, add-on associated costs.
• A single location for defining and managing study administrative data in Oracle Health Sciences Central Designer that streamlines trial workflow and simplifies the design, self-deployment, versioning, and maintenance of clinical studies. Trial sponsors and CROs benefit from a robust staging area that aims to reduce risks associated with migrating studies from development and testing environments to production.
• An advanced modeling environment that streamlines management and validation of in-place, protocol amendments. Organizations can develop and test amendments without taking the study offline, and then automatically push changes into the production environment without manual intervention. This increases study availability and reduces the time and resources needed to make protocol changes, while supporting regulatory compliance with complete audit trails.

"Oracle is leading the way with innovative, secure, and compliant cloud-based solutions that help our industry bring life-improving therapies to market faster and at a lower cost," said James Streeter, vice president, life sciences product strategy, Oracle Health Sciences. "Oracle Health Sciences InForm Cloud Service 6.1 and our broad platform of integrated Oracle Health Sciences Cloud solutions help organizations address complex business requirements head-on by enabling them to adopt new models with confidence and speed. For example, the Oracle Health Sciences Inform 6.1 models for risk-based monitoring and adaptive trials drive greater clinical development, efficiency, and precision."

Additional Information Join the Oracle Health Sciences community on Facebook and follow @OracleHealthSci on Twitter.

About Oracle Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle (NYSE: ORCL), visit oracle.com.

Trademark Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Info
Samantha Thai
Oracle
+1.510.917.5564
Email Contact

Mary Tobin
O'Keeffe & Company
+1.503.658.7396
Email Contact

Source: Oracle Corporation

You May Also Be Interested In

• Oracle (ORCL) U.S. Government Cloud Customers Accelerate Sovereign AI with NVIDIA AI Enterprise
• Oracle (ORCL) U.S. Government Cloud Customers Accelerate Sovereign AI with NVIDIA AI Enterprise
• Bread Financial Holdings, Inc. (BFH) Provides Performance Update for March 2024